EAM
GMED icon

Eagle Asset Management’s Globus Medical GMED Stock Holding History

Eagle Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$32.7M Buy
403,853
+29,573
+8% +$2.09M 0.17% 137
2024
Q2 		$25.4M Buy
374,280
+25,268
+7% +$1.51M 0.14% 156
2024
Q1 		$18.5M Buy
349,012
+66,103
+23% +$3.55M 0.09% 201
2023
Q4 		$15.1M Buy
282,909
+14,398
+5% +$702K 0.08% 214
2023
Q3 		$13.3M Buy
268,511
+24,189
+10% +$1.35M 0.08% 216
2023
Q2 		$14.5M Buy
244,322
+14,854
+6% +$847K 0.08% 213
2023
Q1 		$13M Sell
229,468
-427,481
-65% -$27.4M 0.08% 212
2022
Q4 		$48.1M Sell
656,949
-3,139
-0.5% -$214K 0.29% 123
2022
Q3 		$39.3M Sell
660,088
-275,424
-29% -$16.6M 0.26% 125
2022
Q2 		$52.5M Buy
935,512
+689,367
+280% +$45.3M 0.33% 112
2022
Q1 		$18.2M Sell
246,145
-9,280
-4% -$645K 0.09% 206
2021
Q4 		$18.5M Sell
255,425
-8,296
-3% -$602K 0.08% 221
2021
Q3 		$20.2M Sell
263,721
-70,010
-21% -$5.62M 0.09% 216
2021
Q2 		$25.9M Buy
333,731
+2,508
+0.8% +$178K 0.11% 211
2021
Q1 		$20.5M Buy
331,223
+79,359
+32% +$5.03M 0.09% 241
2020
Q4 		$16.4M Sell
251,864
-71,017
-22% -$4.08M 0.09% 238
2020
Q3 		$15.8M Buy
322,881
+1,524
+0.5% +$78.6K 0.08% 230
2020
Q2 		$15.2M Buy
321,357
+45,032
+16% +$2.17M 0.09% 239
2020
Q1 		$11.8M Buy
276,325
+102,261
+59% +$5.05M 0.07% 249
2019
Q4 		$10.2M Buy
174,064
+3,917
+2% +$213K 0.05% 318
2019
Q3 		$8.7M Buy
170,147
+2,549
+2% +$121K 0.04% 326
2019
Q2 		$7.09M Buy
167,598
+36,111
+27% +$1.57M 0.04% 363
2019
Q1 		$6.5M Buy
131,487
+976
+0.7% +$44.2K 0.03% 367
2018
Q4 		$5.65M Buy
130,511
+777
+0.6% +$38.8K 0.04% 370
2018
Q3 		$7.36M Sell
129,734
-670
-0.5% -$35.3K 0.04% 382
2018
Q2 		$6.58M Buy
130,404
+7,467
+6% +$389K 0.04% 389
2018
Q1 		$6.12M Buy
122,937
+8,301
+7% +$390K 0.03% 394
2017
Q4 		$4.72M Sell
114,636
-41,352
-27% -$1.45M 0.03% 438
2017
Q3 		$4.74M Buy
155,988
+6,550
+4% +$200K 0.03% 440
2017
Q2 		$4.95M Buy
149,438
+2,408
+2% +$75.6K 0.03% 427
2017
Q1 		$4.36M Buy
147,030
+8,476
+6% +$231K 0.03% 442
2016
Q4 		$3.44M Sell
138,554
-26,744
-16% -$608K 0.02% 469
2016
Q3 		$3.73M Buy
165,298
+20,055
+14% +$471K 0.03% 453
2016
Q2 		$3.46M Buy
145,243
+5,031
+4% +$121K 0.02% 468
2016
Q1 		$3.33M Sell
140,212
-8,165
-6% -$200K 0.02% 474
2015
Q4 		$4.13M Sell
148,377
-40,626
-21% -$1.02M 0.03% 432
2015
Q3 		$3.9M Buy
189,003
+14,880
+9% +$377K 0.03% 453
2015
Q2 		$4.47M Buy
174,123
+52,454
+43% +$1.33M 0.03% 453
2015
Q1 		$3.07M Sell
121,669
-29,899
-20% -$728K 0.02% 477
2014
Q4 		$3.6M Sell
151,568
-39,373
-21% -$872K 0.02% 472
2014
Q3 		$3.75M Sell
190,941
-269,362
-59% -$5.54M 0.02% 480
2014
Q2 		$11M Sell
460,303
-55,103
-11% -$1.33M 0.06% 324
2014
Q1 		$13.7M Sell
515,406
-13,793
-3% -$328K 0.08% 305
2013
Q4 		$10.7M Buy
529,199
+386,006
+270% +$7.17M 0.06% 306
2013
Q3 		$2.53M Buy
+143,193
New +$2.48M 0.01% 608

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Eagle Asset Management's GMED Position: Q3 2024 in Review

Eagle Asset Management increased its Globus Medical (GMED) stake by 7.9% in Q3 2024, buying an estimated $2.09M and bringing the position to 403,853 shares worth $32.7M. The position accounts for 0.17% of the portfolio, ranked #137.

Eagle Asset Management first reported a position in GMED in Q3 2013 and has held it in 45 quarters since. The position peaked at $52.5M in Q2 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Eagle Asset Management held 403,853 shares of Globus Medical worth $32.7M as of Q3 2024.
  • Eagle Asset Management bought 29,573 Globus Medical shares in Q3 2024, an estimated $2.09M.
  • Globus Medical made up 0.17% of Eagle Asset Management's portfolio in Q3 2024, its #137 holding.
  • Eagle Asset Management first reported a position in Globus Medical in Q3 2013 and has held it in 45 quarters since.
  • Eagle Asset Management's Globus Medical position peaked at $52.5M in Q2 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.